FDAnews
www.fdanews.com/articles/192705-hemosonics-new-diagnostic-for-hemostasis-system-gains-ce-mark

HemoSonics’ New Diagnostic for Hemostasis System Gains CE Mark

September 12, 2019

HemoSonics has gained the CE Mark for its QStat Cartridge, allowing its Quantra Hemostasis System to be used in trauma surgery and liver transplants settings in hospitals.

The disposable cartridge offers a panel of blood tests for gauging clot time, clot stiffness, fibrinogen and platelet contribution to clot stiffness and clot stability to lysis.

All tests except the clot stability to lysis diagnostic take 25 minutes or less to produce results, which are read on a user-friendly dials interface that requires little training, the devicemaker said.

View today's stories